Moschamindole induces glioma cell apoptosis by blocking Mia40-dependent mitochondrial intermembrane space assembly...

Area of Science:

• Biochemistry
• Oncology
• Pharmacology

Background:

• Glioblastoma multiforme (GBM) is an aggressive brain tumor with limited treatment options.
• Chemoresistance is a major challenge in treating GBM, necessitating novel therapeutic strategies.

Purpose of the Study:

• To investigate the potential of moschamindole (MCD), a compound from Phragmites communis, as a therapeutic agent against GBM.
• To elucidate the mechanism of action of MCD, focusing on its effects on apoptosis and mitochondrial function in GBM cells.

Main Methods:

• Cell-based assays were used to assess MCD's cytotoxicity on GBM cell lines and xenograft models.
• Mechanisms of action were explored using cell cycle analysis, caspase activation assays, mitochondrial membrane potential measurements, PCR, and immunoblot analysis.
• The role of Mia40 in MCD-induced apoptosis and chemoresistance was investigated through overexpression and upregulation studies.

Main Results:

• Moschamindole (MCD) demonstrated significant cytotoxic effects on both TMZ-resistant GBM cell lines and xenograft models.
• MCD induced intrinsic apoptosis, evidenced by cell cycle arrest, caspase-3/7 activation, and mitochondrial dysfunction.
• MCD was found to inhibit Mia40-mediated oxidative folding of mitochondrial proteins, disrupting energy metabolism and inducing apoptosis.
• Overexpression of Mia40 reversed MCD-induced apoptosis and was correlated with GBM chemoresistance.

Conclusions:

• Mia40 is identified as a potential therapeutic target for overcoming glioblastoma chemoresistance.
• Moschamindole (MCD) shows promise as a potential agent for the individualized treatment of chemoresistant GBM, particularly in patients with specific mitochondrial metabolic characteristics and Mia40 expression.